Trial intelligence / Profile preview

LPS-BM: Effects of Human Endotoxemia on Hematopoietic Stem Cells

NCT05570643Completed

Sponsor
Radboud University Medical Center
Start
Jan 2018
Primary completion
Jun 2018
Modality
Biologic
Countries
1
01

Overview

Randomised trial comparing LPS group with Placebo group (2 arms). Primary endpoint: Change in function and transcriptional pathways at 15 days. Started Jan 2018; status: completed.

02

Drugs

lipopolysaccharide endotoxin

Beyond the preview

Go deeper on NCT05570643.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05570643.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call